Page 6 - Slrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Slrn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Slrn Today - Breaking & Trending Today

Acelyrin Shares Fall 11%, Programming Error Found in Arthritis Drug Trial

By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic. ....

Ben Glickman , Article Normal , Biotechnology Services , Healthcare Life Sciences , Financial Performance , Share Price Movement Disruptions , New Products Services , Research Development , Corporate Industrial News , Products Services , New Product Service Testing , Arthritis Rheumatic Conditions , Political General News , Medical Conditions , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Share Price Movement , New Products , Industrial News , New Product , Service Testing , Rheumatic Conditions ,

Stocks to Watch: iBio, Acelyrin

By Sabela Ojea iBio on Monday announced a 20-to-1 reverse stock split. Shares of the biopharmaceutical company declined 8.6% to 26 cents in after-hours. ....

Sabela Ojea , Article Normal , Biotechnology Services , Healthcare Life Sciences , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , Iwe Filter , Routine Market Financial News , Routine Market , Financial News , Life Sciences ,

Acelyrin (NASDAQ:SLRN) Sets New 1-Year Low at $8.91

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $8.91 and last traded at $9.02, with a volume of 560184 shares trading hands. The stock had previously closed at $9.13. Analyst Upgrades and Downgrades SLRN has been the […] ....

Hidradenitis Suppurativa , Jennison Associates , Acelyrin Inc , York Mellon Corp , Td Asset Management Inc , Morgan Stanley , Acelyrin Company Profile , Get Free Report , Capital Management , Montreal Can , New York Mellon Corp , Management Inc , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin (NASDAQ:SLRN) PT Lowered to $30.00 at HC Wainwright

Acelyrin (NASDAQ:SLRN – Free Report) had its price objective reduced by HC Wainwright from $44.00 to $30.00 in a research report report published on Tuesday, MarketBeat.com reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Acelyrin’s FY2026 earnings at ($5.11) EPS and FY2027 earnings at ($5.23) EPS. SLRN […] ....

Piper Sandler , Hidradenitis Suppurativa , Jpmorgan Chase Co , Ghisallo Capital Management , Acelyrin Inc , Morgan Stanley , Ayurmaya Capital Management Company , Franklin Resources Inc , Jefferies Financial Group , Free Report , Moderate Buy , Get Free Report , Capital Management , Maya Capital Management Company , Exoduspoint Capital Management , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn , Lower Price Target , Hc Wainwright ,

Stocks to Watch: Oracle, Acelyrin, Humacyte

By Ben Glickman Oracle reported fiscal first-quarter growth in its cloud business slowed sequentially and compared to the year-ago quarter. Oracle's total. ....

Ben Glickman , Article Normal , Biotechnology Services , Computers Consumer Electronics , Applications Software , Healthcare Life Sciences , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , Iwe Filter , Routine Market Financial News , Routine Market , Financial News , Consumer Electronics , Life Sciences ,